The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The FDA has approved Vertex Pharmaceuticals' Journavx, a new pain medication that doesn't carry the risks of addiction and ...
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
FDA approves Journavx, a non-opioid medication for moderate to severe acute pain. Learn about its efficacy and side effects.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
“Usually when new drugs come out ... of the body for minor dental or cosmetic procedures — block all sodium channels, stopping pain but also leaving the entire area numb, among other side ...